On ECHEMI
Home > Drugs > Shenyang Yaoda Leiyunshang Pharmaceutical Co., Ltd.
Shenyang Yaoda Leiyunshang Pharmaceutical Co., Ltd.
  • Founded in:

    1998-09-16
  • Country:

    China China
  • Address:

    No. 111 Xianghuai Road, Benxi Economic and Technological Development Zone, Liaoning Province
  • Tax NO.:

    91210500711133379A
  • Registered Funds:

    30.8 million yuan
  • Website:

  • Email:

Related Drugs
Yijin hypoglycemic oral liquid
Ginseng, Atractylodes macrocephala, Poria cocos, Cactus, Licorice
Name Description Content CAS NO. Registered Holders
ASIAN GINSENG

Strengthens the spleen and replenishes Qi, promotes the production of body fluids and quenches thirst

More

Strengthens the spleen and replenishes Qi, promotes the production of body fluids and quenches thirst

0
Atractylodis Macrocephalae Rhizoma

Strengthens the spleen and replenishes Qi, promotes the production of body fluids and quenches thirst

More

Strengthens the spleen and replenishes Qi, promotes the production of body fluids and quenches thirst

0
Poria

Strengthens the spleen and replenishes Qi, promotes the production of body fluids and quenches thirst

More

Strengthens the spleen and replenishes Qi, promotes the production of body fluids and quenches thirst

0
cactus

Strengthens the spleen and replenishes Qi, promotes the production of body fluids and quenches thirst

More

Strengthens the spleen and replenishes Qi, promotes the production of body fluids and quenches thirst

0
DGL

Strengthens the spleen and replenishes Qi, promotes the production of body fluids and quenches thirst

More

Strengthens the spleen and replenishes Qi, promotes the production of body fluids and quenches thirst

0
Compound fluorouracil injection
This product is a compound preparation, and its components are: each tube contains 40mg of fluorouracil and 40mg of ginseng polysaccharide. Excipients are: refined soybean lecithin, cholesterol, polysorbate 80, vitamin E, oleic acid, povidone K30, disodium hydrogen phosphate, and sodium dihydrogen phosphate.
Name Description Content CAS NO. Registered Holders
5-Fluorouracil

It is first converted into 5-fluoro-2-deoxyuridine nucleotide in the body, which inhibits thymidine nucleotide synthetase, blocking the conversion of deoxyuridine nucleotide into deoxythymidine nucleotide, thereby inhibiting DNA biosynthesis. In addition, it can also be incorporated into RNA, inhibiting RNA synthesis by preventing uracil and orotic acid from incorporating into RNA. Fluorouracil is a cell cycle-specific drug that mainly inhibits S-phase tumor cells.

More

It is first converted into 5-fluoro-2-deoxyuridine nucleotide in the body, which inhibits thymidine nucleotide synthetase, blocking the conversion of deoxyuridine nucleotide into deoxythymidine nucleotide, thereby inhibiting DNA biosynthesis. In addition, it can also be incorporated into RNA, inhibiting RNA synthesis by preventing uracil and orotic acid from incorporating into RNA. Fluorouracil is a cell cycle-specific drug that mainly inhibits S-phase tumor cells.

40mg 51-21-8 21
Ginseng polysaccharide

It promotes the body's immune function.

More

It promotes the body's immune function.

40mg 0
Ozagrel Sodium for Injection
Ozagrel sodium.
Name Description Content CAS NO. Registered Holders
Ozagrel sodium

This product is a thromboxane synthetase inhibitor that can inhibit the production of TXA2, thus having the effects of anti-platelet aggregation and vasodilation. Animal experiments have shown that intravenous administration can reduce plasma TXB2 levels and the Keto-PGF12/TXB2 ratio, inhibit platelet aggregation caused by different inducers, and prevent cerebral infarction caused by the middle cerebral artery in rats.

More

This product is a thromboxane synthetase inhibitor that can inhibit the production of TXA2, thus having the effects of anti-platelet aggregation and vasodilation. Animal experiments have shown that intravenous administration can reduce plasma TXB2 levels and the Keto-PGF12/TXB2 ratio, inhibit platelet aggregation caused by different inducers, and prevent cerebral infarction caused by the middle cerebral artery in rats.

189224-26-8 10
Compound zinc undecylenate triamcinolone acetonide ointment
This product is a compound preparation, and its components are: every 10 grams contains 2g of zinc undecylenate, 0.5g of undecylenic acid, 0.04g of triamcinolone acetate, and appropriate amount of auxiliary materials.
Name Description Content CAS NO. Registered Holders
Zinc undecylenate

Antifungal drugs have strong fungus inhibition function and certain antipruritic and anti-allergic effects

More

Antifungal drugs have strong fungus inhibition function and certain antipruritic and anti-allergic effects

2g 557-08-4 1
Undecenoic acid

Antifungal drugs have strong fungus inhibition function and certain antipruritic and anti-allergic effects

More

Antifungal drugs have strong fungus inhibition function and certain antipruritic and anti-allergic effects

0.5g 112-38-9 1
Triamcinolone Acetate

Antifungal drugs have strong fungus inhibition function and certain antipruritic and anti-allergic effects

More

Antifungal drugs have strong fungus inhibition function and certain antipruritic and anti-allergic effects

0.04g 0
Fluorouracil Injection
The chemical name of this product is: 5-fluoro-2,4(1H,3H)-pyrimidinedione.
Name Description Content CAS NO. Registered Holders
5-Fluorouracil

This product is first converted into 5-fluoro-2-deoxyuridine nucleotide in the body, which inhibits thymine nucleotide synthetase, blocking the conversion of deoxyuridine nucleotide into deoxythymine nucleotide, thereby inhibiting DNA biosynthesis. In addition, by preventing uracil and orotic acid from incorporating into RNA, the effect of inhibiting RNA synthesis is achieved. This product is a cell cycle-specific drug that mainly inhibits S-phase cells.

More

This product is first converted into 5-fluoro-2-deoxyuridine nucleotide in the body, which inhibits thymine nucleotide synthetase, blocking the conversion of deoxyuridine nucleotide into deoxythymine nucleotide, thereby inhibiting DNA biosynthesis. In addition, by preventing uracil and orotic acid from incorporating into RNA, the effect of inhibiting RNA synthesis is achieved. This product is a cell cycle-specific drug that mainly inhibits S-phase cells.

51-21-8 21
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.